A5079652833- Inflammasome and immune disorders
- Diabetic Foot Ulcer Assessment and Management
- IL-33, ST2, and ILC Pathways
- Eosinophilic Esophagitis
- Bone and Joint Diseases
- Urticaria and Related Conditions
- interferon and immune responses
- Erythropoietin and Anemia Treatment
- Systemic Sclerosis and Related Diseases
- Drug-Induced Adverse Reactions
- Heart Failure Treatment and Management
- Platelet Disorders and Treatments
- Cholesterol and Lipid Metabolism
Gazi University
2022-2025
<title>Abstract</title> Introduction: This study investigates hypersensitivity reactions (HSRs) associated with rituximab therapy in nephrology patients, focusing on identifying potential risk factors. Methods Records of patients treated our unit for kidney diseases were reviewed between January 2019 and June 2024. Demographic, clinical, laboratory data evaluated to identify factors HSRs. Patients premedicated paracetamol, diphenhydramine, corticosteroids before infusions. Binary logistic...
Background Familial Mediterranean Fever (FMF) is an autoinflammatory disease characterized by recurrent fever, serositis, arthritis and erysipelas-like erythema caused mutations over activating caspase-1. As Interleukin (IL)-1 beta, IL-33 a nuclear cytokine from IL-1 family which activated known to take part in pathogenesis of several rheumatic diseases. Objectives The aim this research determining the relationship between serum levels clinical features patients with FMF disease. Methods...
Abstract Background and Aims Iron replacement in treating heart failure (HF) is an issue whose importance has been better understood recent years. Although controversies exist, randomized controlled studies have shown that IV iron treatment reduces mortality improves symptomatology with low EF (HFrEF). not dramatically affected survival preserved (HFpEF). However, there data it might reduce symptoms hospitalizations. For patients chronic kidney disease (CKD) HF, around 60% of them HFpEF....
Background Familial Mediterranean Fever (FMF) is an autoinflammatory disease characterized by recurrent attacks of fever, serositis, arthritis and erysipelas-like erythema. Patient acceptable symptom state (PASS) a evaluation method to assess activity with simple question especially in rheumatic diseases. Objectives We aimed investigate clinical utility PASS FMF patients. Methods The research involved 54 was applied all patients the study. answers were compared laboratory features. Results...